European Parliament
Claude Moraes (PSE ),
in writing
I have supported this report in its intention to alleviate the costs for many of the poorest countries for healthcare and drugs. Whilst I support the intention of Amendment 3 in alleviating these costs, the amendment is inappropriate as it provides for a blanket limit to all patient protection for products related to this field which could distort markets at a global level and potentially harm further development.

